The invention provides compositions and methods for the induction of cancer cell death. The compositions and methods of using them include use of compositions in therapy for the treatment of cancer and for the selective induction of apoptosis in cancer cells. The drug combinations described herein can be synergistic and can have lower neurotoxicity effects than the same amounts of other compounds and combinations of compounds, and can be effective when a particular cancer has become resistant to previously administered therapies.
Original languageEnglish (US)
U.S. patent number10350207
Filing date6/6/16
StatePublished - Jul 16 2019


Dive into the research topics of 'PAC-1 combination therapy'. Together they form a unique fingerprint.

Cite this